GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Net Income Including Noncontrolling Interests

Bioceltix (WAR:BCX) Net Income Including Noncontrolling Interests : zł-15.65 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bioceltix Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Bioceltix's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2024 was zł-3.45 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 was zł-15.65 Mil.

Bioceltix Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Bioceltix's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioceltix Net Income Including Noncontrolling Interests Chart

Bioceltix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
-1.60 -2.35 -4.40 -8.92 -13.69

Bioceltix Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.52 -3.76 -4.21 -4.23 -3.45

Bioceltix Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-15.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioceltix Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Bioceltix's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioceltix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
WAR:SVE WAR:RVU WAR:BIO WAR:MOC WAR:PTG WAR:CTX WAR:MAB WAR:URT WAR:NNG WAR:RDG VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
XI3:Germany
Address
Bierutowska 57-59 Street, Wroclaw, POL, 51-317
Website
https://www.bioceltix.com
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.